Advanced Search

 

Study ID Status Title Patient Level Data
112657 Completed A double-blind, randomized, placebo controlled, dose escalation, multi-centerphase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20antibody, in patients with active rheumatoid arthritis who have previously failedone or more disease modifying anti-rheumatic drugs
112662 Completed Immunogenicity and safety study of GSK Biologicals’ influenza vaccine GSK2186877A in elderly adults. Study Listed on ClinicalStudyDataRequest.com
112668 Completed A Double-Blind, Parallel, Randomized, Placebo-Controlled, Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
112670 Completed A multi-center, placebo-controlled study to evaluate the safety of GSK716155 and its effects on myocardial metabolism, myocardial function, and exercise capacity in patients with NYHA Class II/III congestive heart failure Study Listed on ClinicalStudyDataRequest.com
112676 Terminated Double blind, double-dummy, randomised, placebo controlled study to evaluate the effect of single doses of drug A (lamotrigine) and drug B (vofopitant) alone and in combination on resting motor threshold in healthy subjects Study Listed on ClinicalStudyDataRequest.com
112677 Completed Cervarix long-term safety surveillance using the PGRx information system (PGRx study)
112679 Completed Immunogenicity and safety of GSK Biologicals’ IPV (Poliorix™) in infants Study Listed on ClinicalStudyDataRequest.com
112680 Completed A Phase I, Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of the BRAF Inhibitor GSK2118436 in Subjects with Solid Tumors
112682 Completed Long-term persistence of hepatitis B antibodies and immune response to a hepatitis B vaccine challenge in 12-13 year old adolescents, vaccinated in infancy with GlaxoSmithKline (GSK) Biologicals’ HBV vaccine (Engerix™-B) Study Listed on ClinicalStudyDataRequest.com
112683 Completed An open-label study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ Inactivated Poliomyelitis Vaccine Poliorix administered as a booster dose at 18-24 months of age in healthy toddlers in China. Study Listed on ClinicalStudyDataRequest.com
112691 Completed Immunogenicity and safety study of GSK Biologicals’ monovalent pandemic H5N1 vaccine 1557484A in adults aged 18 – 64 years Study Listed on ClinicalStudyDataRequest.com
112708 Completed Control of Asthma With Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroid Regimens Systematic Review A Meta-analysis of Observational Studies
112745 Completed Safety and immunogenicity study of GSK Biologicals’ Plasmodium falciparum malaria vaccine 257049 administered to HIV infected infants and children Study Listed on ClinicalStudyDataRequest.com
112753 Completed A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112753 Completed A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112754 Completed A randomized, open-label, parallel-group, multicenter study to determine the efficacy and long-term safety of albiglutide compared with insulin in subjects with type 2 diabetes mellitus. Study Listed on ClinicalStudyDataRequest.com
112755 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Pioglitazone With or Without Metformin in Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112756 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112757 Completed A Randomized, Double-blind, Placebo and Active-Controlled, Parallel-group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepiride Compared With Metformin Plus Glimepiride and Placebo and with Metformin plus Glimepiride and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
112758 Completed A phase I/II, a single arm, open-label study of ofatumumab (GSK1841157) in patients with previously treated chronic lymphocytic leukemia
112771 Completed An open label study conducted in healthy subjects to demonstrate bioequivalence between ropinirole prolonged release tablets (ropinirole XL, marketed as REQUIP-MODUTAB™, REQUIP XL™ at 2 mg) manufactured at Crawley and Aranda Study Listed on ClinicalStudyDataRequest.com
112772 Completed Follow-up study to evaluate the long-term immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV (580299) vaccine in healthy female subjects Study Listed on ClinicalStudyDataRequest.com
112773 Completed An open label positron emission tomography study in healthy male subjects to investigate brain DAT and SERT occupancy, pharmacokinetics and safety of single oral doses ofGSK1360707, using 11C- PE2I and 11C-DASB as PET ligands Study Listed on ClinicalStudyDataRequest.com
112776 Completed A randomized, double-blind, placebo-controlled, two-way crossover 7-day study to investigate the safety, tolerability, pharmacodynamics and pharmacokinetics of repeat dose inhaled GW642444 25 μg (micrograms) in children aged 5-11 years with persistent asthma. Study Listed on ClinicalStudyDataRequest.com
112792 Completed Study CR9112792, a study to assess bone mineral density changes in post-menopausal osteoporotic women following discontinuation of ronacaleret or placebo treatment in study CR9108963

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.